EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSOTSG00005037655
Gene Symbol: SSTR2
1 Cross references
186 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOTSG00005040545
Gene Symbol: SSTR2
1 Cross references
190 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSOTSG00005012862
Gene Symbol: SSTR2
1 Cross references
186 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSOTSG00005031300
Gene Symbol: SSTR5
1 Cross references
182 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSOTSG00005028416
Gene Symbol: S1PR1
3 Cross references
194 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSOTSG00005041748
Gene Symbol: SYK
1 Cross references
200 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSOTSG00005042226
Gene Symbol: SRD5A2B
1 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSOTSG00005005604
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOTSG00005045132
Gene Symbol: TACR1
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOTSG00005016686
Gene Symbol: TACR1
1 Cross references
188 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOTSG00005012422
Gene Symbol: TACR1
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOTSG00005045155
Gene Symbol: TACR1
1 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).